These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1128 related items for PubMed ID: 23217554

  • 21. [Influence of histological prostatitis on the clinical features of benign prostatic hyperplasia and prostate cancer].
    Zhang F, Si-Mu-Jiang-Abula A, Zhang LD.
    Zhonghua Nan Ke Xue; 2014 Apr; 20(4):354-8. PubMed ID: 24873164
    [Abstract] [Full Text] [Related]

  • 22. [Correlation of serum prostate specific antigen, the volume and the intravesical prostatic protrusion for diagnosing bladder outlet obstruction in patients with benign prostate hyperplasia].
    Bantis A, Zissimopoulos A, Kalaytzis C, Giannakopoulos S, Sountoulides P, Agelonidou E, Voudalikakis C, Touloupidis S.
    Hell J Nucl Med; 2007 Apr; 10(2):138-43. PubMed ID: 17684595
    [Abstract] [Full Text] [Related]

  • 23. Percent of free serum prostate-specific antigen and histological findings in patients undergoing open prostatectomy for benign prostatic hyperplasia.
    Scattoni V, Raber M, Montorsi F, Da Pozzo L, Brausi M, Calori G, Freschi M, Rigatti P.
    Eur Urol; 1999 Dec; 36(6):621-30. PubMed ID: 10559617
    [Abstract] [Full Text] [Related]

  • 24. [Correlation of histological prostatitis with PSA, prostate volume, PSAD, IPSS, Qmax and PVR in BPH patients].
    Zhang HT, Xu Y, Chang JW, Zhang ZH, Liu RL, Ma BJ.
    Zhonghua Nan Ke Xue; 2012 Mar; 18(3):208-11. PubMed ID: 22474983
    [Abstract] [Full Text] [Related]

  • 25. IGF-II serum levels increase discrimination between benign prostatic hyperplasia and prostate cancer and improve the predictive value of PSA in clinical staging.
    Trojan L, Bode C, Weiss C, Mayer D, Grobholz R, Alken P, Michel MS.
    Eur Urol; 2006 Feb; 49(2):286-92; discussion 292. PubMed ID: 16386354
    [Abstract] [Full Text] [Related]

  • 26. [Prostate-specific antigen as a prostatic tumor marker. Analysis of results in 206 patients].
    Rodríguez Duarte C.
    Arch Esp Urol; 1991 Feb; 44(6):697-700. PubMed ID: 1722962
    [Abstract] [Full Text] [Related]

  • 27. Does gland histopathology correlate with mode of presentation and surgical complications in benign prostatic hyperplasia?
    Elmalik EM, Ibrahim AI, Ghali AM, Murad N, Rashid M.
    East Afr Med J; 1997 Sep; 74(9):586-90. PubMed ID: 9487437
    [Abstract] [Full Text] [Related]

  • 28. [Changes in the levels of prostate-specific antigen and its molecular forms with alpha 1-antichymotrypsin in patients with benign prostatic hyperplasia].
    Grigor'ev ME, Mazo EB, Chekhonin VP.
    Urol Nefrol (Mosk); 1998 Sep; (4):33-7. PubMed ID: 9727319
    [Abstract] [Full Text] [Related]

  • 29. The impact of systematic prostate biopsy on prostate cancer incidence in men with symptomatic benign prostatic hyperplasia undergoing transurethral resection of the prostate.
    Ornstein DK, Rao GS, Smith DS, Andriole GL.
    J Urol; 1997 Mar; 157(3):880-3; discussion 883-4. PubMed ID: 9072591
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
    Hirao Y, Ozono S, Kagebayashi Y, Yoshi M, Tani Y, Uemura H, Momose H, Okajima E.
    Hinyokika Kiyo; 1996 Oct; 42(10):795-804. PubMed ID: 8951478
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Prostate biopsy in patients with long-term use of indwelling bladder catheter: what is the rationale?
    Antunes AA, Barbosa JA, Reis ST, Guariero MS, Fukushima JT, Dall'oglio MF, Freire Gde C, Lucon AM, Leite KR, Srougi M.
    Urol Oncol; 2012 Sep; 30(5):620-3. PubMed ID: 20933446
    [Abstract] [Full Text] [Related]

  • 34. Prostate inflammation. Association with benign prostatic hyperplasia and prostate cancer.
    Abdel-Meguid TA, Mosli HA, Al-Maghrabi JA.
    Saudi Med J; 2009 Dec; 30(12):1563-7. PubMed ID: 19936421
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Aggressiveness and extent of prostatic inflammation relates with serum PSA levels in type IV prostatitis].
    Man LB, Li GZ, Huang GL, Wang JW, Liu BY.
    Zhonghua Nan Ke Xue; 2012 Aug; 18(8):710-4. PubMed ID: 22934516
    [Abstract] [Full Text] [Related]

  • 37. Bladder catheterization and a plasma prostate-specific antigen in patients with benign prostatic hyperplasia and complete urine retention.
    Dutkiewicz S, Stepień K, Witeska A.
    Mater Med Pol; 1995 Aug; 27(2):71-3. PubMed ID: 8935194
    [Abstract] [Full Text] [Related]

  • 38. [Changes of serum total PSA and free PSA in patients with prostate carcinoma and benign prostate hyperplasia].
    Gao ZW, Liu G, Sheng BW.
    Ai Zheng; 2004 Jun; 23(6):701-3. PubMed ID: 15191675
    [Abstract] [Full Text] [Related]

  • 39. Does intraprostatic inflammation have a role in the pathogenesis and progression of benign prostatic hyperplasia?
    Mishra VC, Allen DJ, Nicolaou C, Sharif H, Hudd C, Karim OM, Motiwala HG, Laniado ME.
    BJU Int; 2007 Aug; 100(2):327-31. PubMed ID: 17617139
    [Abstract] [Full Text] [Related]

  • 40. Is screening for prostate cancer necessary in men with symptoms of benign prostatic hyperplasia?
    Hall MC, Roehrborn CG, McConnell JD.
    Semin Urol Oncol; 1996 Aug; 14(3):122-33. PubMed ID: 8865473
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 57.